Investor Relations

Analyst Coverage

Revance Therapeutics is covered by the following analysts.

Firm Analyst
Barclays
Douglas Tsao
Cantor Fitzgerald
Louise Chen
Cowen and Company
Ken Cacciatore
Goldman Sachs
Dana Flanders
Guggenheim
Rohit Vanjani
JMP Securities
Don Ellis
Mizuho
Difei Yang, Ph.D.
Needham
Serge Belanger
Piper Jaffray & Company
David Amsellem
SunTrust Robinson Humphrey, Inc.
John T. Boris
William Blair
Tim Lugo

Revance Therapeutics, Inc. is followed by the analysts listed above. Please note that any opinions, estimates or forecasts regarding Revance Therapeutics, Inc.'s performance made by these analysts are theirs alone and do not represent opinions, forecasts or predictions of Revance Therapeutics, Inc. or its management. Revance Therapeutics, Inc. does not by its reference above or distribution imply its endorsement of or concurrence with such information, conclusions or recommendations.

Shareholder Tools Request Printed Materials Request Email Alerts Download Library RSS News Feeds Share this Page Search Investor Site
Shareholder Tools
Printed Materials
Download Library
RSS News Feeds
Search